3470-46-0

Usage

Uses

Used in Pharmaceutical Synthesis:
4-[(4-METHYLPHENYL)SULFONYL]PIPERIDINE HYDROCHLORIDE is used as a key intermediate in the synthesis of potential pharmaceuticals for its ability to contribute to the development of new drugs with therapeutic potential.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 4-[(4-METHYLPHENYL)SULFONYL]PIPERIDINE HYDROCHLORIDE is used as a research compound to explore its pharmacological properties, aiming to understand its potential as a therapeutic agent for various medical conditions.
Used in Organic Synthesis as a Reagent:
4-[(4-METHYLPHENYL)SULFONYL]PIPERIDINE HYDROCHLORIDE is utilized as a reagent in organic synthesis for the preparation of other compounds, highlighting its versatility in chemical reactions and its role in creating new chemical entities.
If there are specific industries or applications mentioned in the materials that are not covered above, they should be listed separately as follows:
Used in [Specific Application Industry]:
4-[(4-METHYLPHENYL)SULFONYL]PIPERIDINE HYDROCHLORIDE is used as [specific application type] for [specific application reason].

InChI:InChI=1/C12H17NO2S.ClH/c1-10-2-4-11(5-3-10)16(14,15)12-6-8-13-9-7-12;/h2-5,12-13H,6-9H2,1H3;1H

Upstream product

• 124-38-9 carbon dioxide 
• 144464-66-4 5-oxo-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid methyl ester 
• 3470-50-6 6-Hydroxy-1-tetralone 
• 144464-64-2 5-oxo-5,6,7,8-tetrahydronaphthalen-2-yl trifluoromethanesulfonate 
• 50878-03-0 N-(5,6,7,8-tetrahydronaphth-2-yl)acetamide 
• 3470-53-9 6-amino-1-tetralone 
• 90401-84-6 6-cyano-1-tetralone 

Downstream Products

• 90401-85-7 ethyl 5-oxo-5,6,7,8-tetrahydronaphthalene-2-carboxylate 
• 703-67-3 6-fluoro-3,4-dihydronaphthalen-1(2H)-one 
• 1242847-72-8 N-[(1R)-6-[(4-fluoropiperidin-1-yl)methyl]-1,2,3,4-tetrahydronaphthalen-1-yl]-2-[2-(p-tolylsulfonyl)-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-1-yl]acetamide 
• 1242847-73-9 2-(2-tosyl-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-1-yl)-N-((R)-6-((2,2,2-trifluoroethylamino)methyl)-1,2,3,4-tetrahydronaphthalen-1-yl)acetamide 
• 1242847-70-6 N-[(1R)-6-[(tert-butylamino)methyl]-1,2,3,4-tetrahydronaphthalen-1-yl]-2-[2-(p-tolylsulfonyl)-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-1-yl]acetamide 
• 144464-66-4 5-oxo-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid methyl ester 
• 920302-12-1 C₂₇H₂₄FNO₂ 
• 920302-32-5 9-(4-Butyl-phenyl)-5,11-dihydro-6H-benzo[a]carbazole-3-carboxylic acid 
• 119035-22-2 1-(1-oxo-1,2,3,4-tetrahydro-6-naphthoyl)-4-(3,4,5-trimethoxybenzyl)piperazine hydrochloride 
• 331760-40-8 N-(4-bromophenyl)-6-[(dimethylamino)methylidene]-5-oxo-5,6,7,8-tetrahydro-2-naphthalenecarboxamide 
• 66362-06-9 C₂₀H₂₁NO₅S 

Relevant academic research and scientific papers

Nickel-catalyzed carboxylation of aryl and heteroaryl fluorosulfates using carbon dioxide

The development of efficient and practical methods to construct carboxylic acids using CO2 as a C1 synthon is of great importance. Nickel-catalyzed carboxylation of aryl fluorosulfates and heteroaryl fluorosulfates with CO2 is described, affording arene carboxylic acids with good to excellent yields under mild conditions. In addition, a one-pot phenol fluorosulfation/carboxylation is developed.

A DOR receptor antagonist compound as

The invention provides a compound used as a DOR receptor antagonist. The structural formula of the compound is as shown in the specification. In comparison with the prior art, the invention expounds a pharmaceutical composition and a preparation containin

Melanin concentrating hormone antagonist

A melanin-concentrating hormone antagonist which comprises a compound of the formula: wherein Ar1 is a cyclic group which may have substituents; X is a spacer having a main chain of 1 to 6 atoms;Y is a bond or a spacer having a main chain of 1